Splice Bio, a spin-off of Princeton University and a CataloniaBio & HealthTech member, has appointed Jean-Philippe Combal as chairman of its Board of Directors. Combal is a proven senior executive and entrepreneur with 30 years of experience in the pharmaceutical and biotechnology industry (GenSight Biologics, Galderma International, Fovea-Sanofi, among others) and particularly in the field of gene therapy. Currently, he is co-founder and executive director of Vivet Therapeutics (France).
The company is backed by Ysios Capital, Asabys Partners and Caixa Capital Risc.
Photo: Jean-Philippe Combal - © Splice Bio
You may also be interested in:
Comments